Form 4: Abbott Laboratories Director Acquires Stock Equivalent Units

Director John G. Stratton acquired 324 stock equivalent units of Abbott Laboratories on December 31, 2024, through director fees credited to a grantor trust.

Summary

• On December 31, 2024, John G. Stratton, a director of Abbott Laboratories, acquired 324 stock equivalent units.
• These units were obtained as director fees credited to a stock equivalent unit account under a grantor trust.
• The price of the stock equivalent units was $113.11.
• Following the transaction, Stratton beneficially owns 11,650 stock equivalent units.
• These units earn the same return as if the fees were invested in Abbott shares and are generally paid in cash at age 65 or upon retirement from the board.
• The balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing relationship between the director and the company. The sentiment is neutral to slightly positive.

Positives

• The acquisition of stock equivalent units demonstrates the director's continued investment in Abbott Laboratories.
• The dividend reinvestment feature further increases the director's stake in the company.

Future Outlook

The stock equivalent units are generally paid in cash at age 65 or upon retirement from the board.

Industry Context

This filing is a routine disclosure of a director's change in beneficial ownership, which is common for publicly traded companies. It reflects compensation practices for board members.

Comparison to Industry Standards

• Director compensation in the form of stock or stock equivalent units is a common practice among large, publicly traded companies like Abbott Laboratories.
• Companies such as Johnson & Johnson and Pfizer also utilize similar compensation structures to align the interests of their directors with those of the shareholders.
• The specific amount and terms of the stock equivalent units may vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
• It reinforces the alignment of the director's interests with those of the shareholders.

Key Dates